Draft Guidance on Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical trial
Today, from Revio, we would like to share with you a summary of the Food and Drug Administration (FDA) draft Guideline on Studying Multiple Versions of a Cellular or Gene…
